Centene Quote - 1CNC | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Italy
BIT
Centene Corp (1CNC) Share Price

Centene Corp (1CNC)

59.40

0.00

( 0.00% )

Updated: 08:10:39

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

59.40

Bid

57.67

Ask

59.56

Volume

0.00

0.00 Day's Range 0.00

56.64 52 Week Range 70.15

Market Cap

Previous Close

59.40

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

141

Shares Outstanding

526,030,000

Dividend Yield

-

PE Ratio

12.42

Earnings Per Share (EPS)

5.14

Revenue

154B

Net Profit

2.7B

Sector

Hospital & Medical Svc Plans

Industry

Hospital & Medical Svc Plans

Website

www.centene.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Centene Corp is listed in the Hospital & Medical Svc Plans sector of the Italian Stock Exchange with ticker 1CNC. The last closing price for Centene was 59.40 €. Over the last year, Centene shares have traded in a share price range of 56.64 € to 70.15 €.

Centene currently has 526,030,000 shares outstanding. The market capitalization of Centene is 31.25 € billion. Centene has a price to earnings ratio (PE ratio) of 12.42.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.29	2.21992772328	58.11	59.4	58.11	155	58.755	DE
4	2.76	4.87288135593	56.64	63.32	56.64	141	58.23469417	DE
12	2.76	4.87288135593	56.64	63.32	56.64	141	58.23469417	DE
26	-9.29	-13.5245304993	68.69	68.69	56.64	117	59.6198533	DE
52	-6.65	-10.0681302044	66.05	70.15	56.64	126	61.3576869	DE
156	-6.65	-10.0681302044	66.05	70.15	56.64	126	61.3576869	DE
260	-6.65	-10.0681302044	66.05	70.15	56.64	126	61.3576869	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WPSQ26Pasquarelli Auto SpA	0.0195 € (29.14%)	14k
1PLTRPalantir Technologies Inc	44.67 € (16.39%)	34.95k
1FEY2Fuelcell Energy Inc	0.38 € (12.69%)	3.5k
NTWNetweek SpA	0.018 € (12.50%)	7k
ESAUEsautomotion SPA	2.98 € (12.03%)	17.5k
AIMAA4aim Sicaf SpA	0.03 € (-57.14%)	26.13k
WABTGAlfio Bardolla Training Group Spa	0.1698 € (-22.71%)	34.96k
1UNUniper SE	43.81 € (-20.35%)	15
1CVACleveland Cliffs Inc	11.212 € (-10.19%)	10.71k
EPRBEprcomunicazione spa	1.22 € (-9.63%)	74.9k
TITTelecom Italia SpA	0.2286 € (-1.25%)	82.1M
ISPIntesa Sanpaolo Spa	4.096 € (0.68%)	50.96M
TITRTelecom Italia	0.263 € (-1.68%)	14.97M
SPMSaipem Spa	2.23 € (0.36%)	12.56M
ENELEnel Spa	7.028 € (-0.04%)	6.4M

ddls

ddls 3 minutes ago

Really folks, the biggest failure on pinkstreet seriously!😎

02opida

02opida 3 minutes ago

GREGG THE GREEK

GREGG THE GREEK 3 minutes ago

Awesome !!

Then it won't matter to you one way or the other. Closure is good. I always tell all everyone to do what gives them peace. Selling out now sounds like it might do so for you...assuming you haven't already done so.

Everything isn't for everyone. I know when I

m0n

m0n 3 minutes ago

Having the CEO on Stock podcasts telling BooBs who buy OTC stonks isn't the way to do it on multiple interviews LoL.

What a Joke

02opida

02opida 3 minutes ago

Risk

Risk 3 minutes ago

Sorry TJ I am confused OS up 200m?

02opida

02opida 4 minutes ago

I pick HARRIS to win

JamesF1

JamesF1 4 minutes ago

lol. Today might be the worst possible day for Elite to release news. The election has all the attention. It is poor timing to issue a press release when a large percentage of the population is preoccupied with other events.

02opida

02opida 4 minutes ago

cold & sunny out in Central pa this ELECTION day

longtermbeliever

longtermbeliever 4 minutes ago

a lot of sick people's out there just makeup lies for a living.SO SAD.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOONGS

AMB67

AMB67 4 minutes ago

In addition, patients in both the US and abroad diagnosed with solid metastatic tumors in their lymph nodes will have an opportunity to be treated with RadioGel when clinical trials begin. Also very important.

After several years of just reports on bench and animal testing I'm SO look

Monksdream

Monksdream 4 minutes ago

BNOX there it goes
https://ih.advfn.com/markets/nasdaq/premarket

02opida

02opida 5 minutes ago

Freight > media

ZRock

ZRock 5 minutes ago

hmmm, almost 3 weeks since last PR from KSCP mngt . that's a bit unsual..

threebabiesbusy

threebabiesbusy 5 minutes ago

JMHO….that’s a good time to buy before the vultures sweep in.

02opida

02opida 5 minutes ago

New TAX Credits a coming

ddls

ddls 5 minutes ago

Really folks, BIEL is too hot to touch. Seriously!😎

bucks2pennies

bucks2pennies 5 minutes ago

It is hard to believe that GTCH was once prolific in issuing PRs, yet the quiet period has expanded beyond 6 months. Nothing to brag about? PRs require a higher level of the need for "proof" than posting on FB? Has the gas been let out of their 'ego balloons' such that their brag and confidence

02opida

02opida 5 minutes ago

videoRoB1

videoRoB1 5 minutes ago

That’s a strange question.

frrol

frrol 5 minutes ago

Yes, ceterus paribus you'd get a higher p-val from a lower n for a sample (ie, subgroup) taken from a larger population.

The S1 variant analysis was good to see, but it isn't definitive. The company notably didn't provide the Cohen's D. Disappointing, but shouldn't be a surprise given

02opida

02opida 5 minutes ago

Bio > Health Pills > Diseases & more

Bearslayer

Bearslayer 5 minutes ago

She sat by idly while her cognitively impaired boss shriveled up. She said nothing then is part of a coup to toss him.
She can't be trusted. She's not for the people. She's for herself, greed and handcuffing the great citizens of the Democracy. So the elite can dictate and manipulate us like

Screech691

Screech691 6 minutes ago

Check out the SGTM chart, breakout could be setting up https://www.tradingview.com/chart/SGTM/kBGNCLCz-SGTM-descending-wedge-pattern-ripe-for-a-breakout/?social_toast=true

First Mexican Gold

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions